Motility & Functional GI · Article 124

How Should Functional Dyspepsia Be Diagnosed and Treated?

Functional dyspepsia requires a structured, evidence-based clinical approach. This review summarizes the key diagnostic, management, monitoring and decision points for gastroenterology and hepatology practice.

Functional dyspepsia clinical reference — Related free clinical resource: Clinical Pharmacology.

Functional dyspepsia: practical clinical approach

This page focuses on Functional dyspepsia with emphasis on decisions that change patient care, common pitfalls, and the current evidence base.

External guidance for Functional dyspepsia

Clinical takeaway: For Functional dyspepsia, decisions should integrate current guidelines, patient-specific risk, and the evidence summarized below.

Answer first: Functional dyspepsia is diagnosed when bothersome postprandial fullness, early satiation, epigastric pain or burning persists without structural disease that explains the symptoms. Management should be positive rather than endless exclusion: test and treat H. pylori where appropriate, use endoscopy according to age/alarm-risk context, then offer a PPI trial, followed by neuromodulator or prokinetic therapy when symptoms persist. Diet and gut-brain interventions should be individualized.

Use symptom phenotype

Postprandial distress syndrome is dominated by early satiety/fullness; epigastric pain syndrome by pain/burning. Overlap is common and treatment should follow the dominant symptom rather than the label alone.

Exclude the right things

H. pylori testing is important. Endoscopy is appropriate according to age, cancer risk and alarm features, but routine imaging and repeated endoscopy are usually low yield after a competent evaluation.

Treat sequentially

PPI therapy is reasonable first-line after H. pylori management. Low-dose tricyclic antidepressants can reduce visceral pain/hypersensitivity. Prokinetics may help selected postprandial patients. Psychological therapies can be useful when symptoms are persistent and disabling.

Practical clinical algorithm

Identify the dominant dyspeptic symptom pattern.
Test/treat H. pylori where appropriate.
Perform endoscopy when age, cancer risk or alarm features warrant it.
Trial PPI therapy.
If persistent, consider low-dose TCA, then selected prokinetic or gut-brain therapy.
Reassess diagnosis if progressive vomiting, weight loss or new alarm features develop.

Common mistakes to avoid

Calling every patient with upper-abdominal symptoms ‘GERD.’
Ordering gastric emptying studies for all dyspepsia.
Using escalating PPI doses indefinitely despite no response.
Ignoring H. pylori.
Failing to explain functional dyspepsia as a positive diagnosis.

Trainee takeaway

Functional dyspepsia is common, real and treatable; success comes from a structured sequence rather than repeated exclusionary testing.

Frequently asked questions

Does normal endoscopy prove functional dyspepsia?

It supports the diagnosis when the symptom pattern and appropriate evaluation fit.

Is gastroparesis the same disorder?

No. Gastroparesis requires objective delayed gastric emptying.

Do antidepressants mean the symptoms are psychiatric?

No. Low-dose neuromodulators are used for visceral pain processing, independent of depression.

References

1. Thomson ABR. Practice Review in Gastroenterology. CAPstone Academic Publishers; 2014.

2. Thomson ABR. Guideline-Based Management in Gastroenterology. CAPstone Academic Publishers; 2015.

3. Moayyedi PM, Lacy BE, Andrews CN, Enns RA, Howden CW, Vakil N. ACG and CAG Clinical Guideline: Management of Dyspepsia. Am J Gastroenterol. 2017;112:988-1013.

4. Ford AC, Mahadeva S, Carbone MF, Lacy BE, Talley NJ. Functional dyspepsia. Lancet. 2020;396:1689-1702.

Educational content only. Clinical decisions should incorporate the individual patient, local resources, product labeling, and the most current applicable guideline or regulatory information.

← Back to Clinical Questions